(Re)New(ed) - Health2Market

advertisement
Health
Market
The (Re)New(ed) Ethics of Utilization
IPR and The Role of the University in the Knowledge Economy
Bowman Heiden
CIP – Center for Intellectual Property
University of Gothenburg
Chalmers University of Technology
[email protected]
The University in the Knowledge Economy
In 2007, Prof. Ulf Petrusson
published a book together with
Vinnova, the Swedish Innovation
Agency, entitled The University in
the Knowledge Economy in
relation to the governmental
review to change legislation
regarding ownership of research
results originating from public
funding.
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Research and Innovation
In 2012, Prof. Ulf Petrusson
published a book together the
Swedish Finance Ministry entitled
Research and Innovation – state
governance of collaboration and
utilization activities in higher
education in relation to the
change in legislation mandating
that universities take on the
formal responsibility to manage
utilization activities.
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
”I think you should be more explicit here in step two”
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Knowledge Management Platform
A system to support the utilization of university research
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Utilization Logics
The academic environment operates to
make knowledge available in open
contractual structures/networks
Contractual
network
Assets are managed as portfolios of
background and foreground research results
in contract-based knowledge platforms
The academic environment operates to
make knowledge available as products
and knowledge organizations
Assets are packaged as controlled
ideas, which can be further developed
as innovations.
Innovation process
Assets are managed as applicable research
results – which may require patentability
or other types of control
The academic environment operates to
make knowledge available/applicable
to specific stakeholders
Applicable to specific stakeholders
The academic environment operates to
make knowledge available to the public
Public domain
Assets are transferred to the public
domain without any intellectual
property right restrictions
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
CHALLENGE
HOW DO WE MANAGE KNOWLEDGE?
?
How can we define knowledge that is diffuse and
difficult to communicate…
!
…and create a clear basis for decisions
involving the knowledge and results
generated in the research?
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Managing research results as intellectual assets
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
IA Capture Process
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
IA Positioning
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
DECISION MAKING
ANALYZING INTELLECTUAL ASSETS
We can analyze how assets can create value
based on a number of parameters:
1. What is the potential to create value in
different contexts?
2. How well do we control the asset?
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
IAM as means to make strategic decisions
Further development
Venture creation
• What technology is lacking?
• What rights do we need to
exploit the technology?
• What should be further
developed in-house?
• What people and
organizational activities do
we need?
• What to buy/license from
others?
Patenting/IPRs
Collaboration
Business modeling
• What should be patented?
• Where do we need strategic
partnerships?
• What is our unique technology
and what utilities does it create?
• What of the things we bring
to the table are valuable?
• Is there a need for it?
• What can be discussed
freely/what is secret?
• How could it be packaged?
• What other governance
mechanisms are needed
to protect our resources?
• What should be done
regarding others’ IPRs?
• What could we offer to others?
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Session Participants





David Pardoe, Head of Growth Projects, MRC (Medical
Research Council) Technologies, United Kingdom
Morris Berrie, Co- Founder TTS Global Initiative, United
Kingdom
Peter Heydebreck , Deputy Chairman, innoveas
international, United Kingdom
Olivier Lescroart, IP Officer, KU Leuven Research and
Development, Belgium
Niclas Lundh, Senior Officer for Research and External
Relations, Sahlgrenska Academy, University of
Gothenburg, Sweden
The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme
Download